Company profile: Dark Horse Consulting
1.1 - Company Overview
Company description
- Provider of consulting services for cell and gene therapy development, including process codification and evaluation, development planning, analytical development for potency assays, buyer-side diligence, Phase III readiness reviews, comparability study design to demonstrate manufacturing equivalence, contract manufacturing management, facility design, and device development for manufacturing equipment.
Products and services
- Due Diligence of Phase III Readiness for Cell Therapy: Executes comprehensive reviews assessing Phase III readiness and BLA suitability via process analysis, material suitability checks, and quality management system evaluation, using a BLA-oriented approach
- Buyer-Side Diligence in CGT Tools & Tech: Performs detailed technical analysis of target technologies through patent portfolio evaluation, competitive analysis, and market performance assessment, employing an IP-driven approach
- Process Codification at Early Clinical Phase: Architects process codification to enhance internal clarity, improve communication with external stakeholders, and support regulatory submissions, delivering a submission-ready approach
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dark Horse Consulting
Bachem
HQ: Switzerland
Website
- Description: Provider of full-service biochemicals to the pharma and biotech industry; an independent, technology-based company specializing in process development and GMP manufacturing of peptide and oligonucleotide APIs, complex organic molecules, and innovative research biochemicals. Offers research-grade and GMP peptides, oligonucleotide NCE development, commercial APIs and generics, catalog peptides, custom peptide synthesis, amino acid derivatives, and products for diagnostics and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bachem company profile →
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
Biose
HQ: France
Website
- Description: Provider of pharmaceuticals based on live bacteria, with 60 years of experience and specialized skills across discovery, process development, manufacturing, and registration, focused on health through microbiota and microbiome science.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biose company profile →
INW
HQ: United States
Website
- Description: Provider of manufacturing services for dietary supplements, sports nutrition, cosmetics, tablets, and other wellness products, producing powders (meal replacements, plant-based protein, vitamin herbal), capsules and tablets (amino acids, delayed release, multivitamins), soft gels (fish oil, omega-3), nutritional gels, functional beverages (energy shots, aloe vera), and bars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full INW company profile →
Casimir
HQ: United States
Website
- Description: Provider of virtual trials and remote assessments and qualitative research centered on the patient experience, capturing the real-world impact of treatment interventions on patient quality-of-life through smart outcome measures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Casimir company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dark Horse Consulting
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dark Horse Consulting
2.2 - Growth funds investing in similar companies to Dark Horse Consulting
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dark Horse Consulting
4.2 - Public trading comparable groups for Dark Horse Consulting
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →